Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.12 | 0.7 |